Mereo BioPharma Group plc
MREO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $517,737 | $304,668 | $90,480 | $186,775 |
| - Cash | $69,802 | $57,421 | $56,334 | $94,296 |
| + Debt | $6,429 | $5,952 | $12,773 | $16,760 |
| Enterprise Value | $454,364 | $253,199 | $46,919 | $109,239 |
| Revenue | $0 | $10,000 | $0 | $49,213 |
| % Growth | -100% | – | -100% | – |
| Gross Profit | $0 | $7,426 | $257 | $25,044 |
| % Margin | – | 74.3% | – | 50.9% |
| EBITDA | -$40,795 | -$26,056 | -$39,979 | $25,487 |
| % Margin | – | -260.6% | – | 51.8% |
| Net Income | -$43,253 | -$29,466 | -$42,122 | $17,174 |
| % Margin | – | -294.7% | – | 34.9% |
| EPS Diluted | -0.29 | -1,100.22 | -1,750.35 | 749.65 |
| % Growth | 100% | 37.1% | -333.5% | – |
| Operating Cash Flow | -$32,834 | -$21,132 | -$48,821 | -$7,071 |
| Capital Expenditures | -$699 | -$419 | -$13 | -$722 |
| Free Cash Flow | -$33,533 | -$21,551 | -$48,834 | -$7,793 |